Cargando…
Mechanism of Fei-Xian Formula in the Treatment of Pulmonary Fibrosis on the Basis of Network Pharmacology Analysis Combined with Molecular Docking Validation
OBJECTIVE: This study aimed to clarify the mechanism of Fei-Xian formula (FXF) in the treatment of pulmonary fibrosis based on network pharmacology analysis combined with molecular docking validation. METHODS: Firstly, ingredients in FXF with pharmacological activities, together with specific target...
Autores principales: | Chen, Xiao-Li, Tang, Cheng, Xiao, Qing-Ling, Pang, Zhong-Hua, Zhou, Dan-Dan, Xu, Jin, Wang, Qi, Zhao, Ya-xi, Zhu, Qi-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357467/ https://www.ncbi.nlm.nih.gov/pubmed/34394391 http://dx.doi.org/10.1155/2021/6658395 |
Ejemplares similares
-
Mechanism of Action of Bu-Fei-Yi-Shen Formula in Treating Chronic Obstructive Pulmonary Disease Based on Network Pharmacology Analysis and Molecular Docking Validation
por: Wu, Longchuan, et al.
Publicado: (2020) -
Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis
por: Wang, Juan, et al.
Publicado: (2021) -
Reveal the Mechanisms of Yi-Fei-Jian-Pi-Tang on Covid-19 through Network Pharmacology Approach
por: Lang, Wanying, et al.
Publicado: (2022) -
Qing Fei Hua Xian Decoction ameliorates bleomycin-induced pulmonary fibrosis by suppressing oxidative stress through balancing ACE-AngII-AT1R/ACE2-Ang-(1-7)-Mas axis
por: Li, Rui-jie, et al.
Publicado: (2023) -
Network pharmacology-based identification of key pharmacological pathways of Yin–Huang–Qing–Fei capsule acting on chronic bronchitis
por: Yu, Guohua, et al.
Publicado: (2016)